Press Releases

Ares Capital Corporation to Host Investor Day on May 21, 2024 May 10, 2024 06:30AM

Live Video Stream to Begin at 1:15 p.m. ET

NEW YORK, NY / ACCESSWIRE / May 10, 2024 / Ares Capital Corporation (NASDAQ: ARCC) will host an Investor Day on Tuesday, May 21, 2024 via a live video stream. During the event, members of the Company's senior leadership team will provide an update on the firm's business and outlook. The presentation will begin at 1:15 p.m. Eastern Time.

To register for the event and to access the Investor Day presentation and live video stream,... (continue reading...)

Summary of Tallinna Sadam webinars May 10, 2024 06:55AM

On 10 May 2024, Tallinna Sadam held a webinar for investors where the chairman of the management board Valdo Kalm and member of the management board CFO Andrus Ait presented the unaudited results of the Group for 2024 Q1.

Tallinna Sadam would like to thank all participants. The recording of the webinars can be followed up in Estonian and in English language. The presentation is available at the company’s web page: https://www.ts.ee/en/investor/presentations/ .

... (continue reading...)

Boussard & Gavaudan Investment Management LLP: Form 8.3 - Network International Holdings PLC May 10, 2024 06:53AM

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)

1.        KEY INFORMATION

(a)        Full name of discloser:Boussard & Gavaudan Investment Management LLP Boussard & Gavaudan Gestion SAS acting on behalf of various funds(b)        Owner or controller of interests and short positions disclosed, if different... (continue reading...)

Man Group PLC : Form 8.3 - Barratt Developments plc May 10, 2024 06:51AM

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)

1.        KEY INFORMATION

(a)   Full name of discloser:Man Group PLC(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor... (continue reading...)

Protalix BioTherapeutics Reports First Quarter 2024 Financial and Business Results May 10, 2024 06:50AM

Company to host conference call and webcast today at 8:30 a.m. EDT

CARMIEL, Israel, May 10, 2024 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein expression system, today reported financial results for the quarter ended March 31, 2024, and provided a business... (continue reading...)